Walleye Capital LLC Amylyx Pharmaceuticals, Inc. Transaction History
Walleye Capital LLC
- $20.4 Billion
- Q1 2025
A detailed history of Walleye Capital LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 250,888 shares of AMLX stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250,888
Previous 23,000
990.82%
Holding current value
$1.58 Million
Previous $86,000
932.56%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AMLX
# of Institutions
149Shares Held
72.6MCall Options Held
148KPut Options Held
98.7K-
Perceptive Advisors LLC New York, NY7.87MShares$49.6 Million1.17% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$37.4 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$35.9 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$25.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.08MShares$19.4 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $369M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...